Detalhe da pesquisa
1.
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
Ann Hematol
; 103(2): 609-621, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957371
2.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Transplant Cell Ther
; 30(2): 213.e1-213.e12, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042256